No profile data available.
AIM ImmunoTech Inc. (AIM) is a healthcare company in the immunodeficiency treatment drugs industry, based in Ocala, United States, with about 19 full-time employees.
Its market capitalization was $7.18 million as of October 9, 2026.
Figures from company filings and market data; market data as of October 9, 2026.
, an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.
$7.18 million as of October 9, 2026.
Listed companies of a similar size in the same industry (immunodeficiency treatment drugs) include Pharvaris N.v. (PHVS), Pharming Group N.v. (PHAR), X4 Pharmaceuticals, Inc. (XFOR), Enzolytics, Inc. (ENZC).